If this is your company, CONTACT US to activate Packbase™ software to build your portal.

    News

    Quick Contact
    SGD Pharma launches industry first ready-to-use sterile 100 ml molded glass vials in SG EZ-fill packaging technology

    SGD Pharma launches industry first ready-to-use sterile 100 ml molded glass vials in SG EZ-fill packaging technology

    Worldwide glass primary packaging supplier SGD Pharma has announced the introduction of its 100H ml Ready-to-Use (RTU) Type I molded glass vials for aseptic fill/finish of parenteral drug products. The addition of 100 ml molded glass vials to the Sterinity platform is pioneering, with SGD Pharma being the first global molded glass manufacturing company to offer this size of solution in the RTU market.

    03 Mar 22

    SGD Pharma speeds up time to market with industry first Ready-to-Use Nest & Tub packaging solution for molded glass vials

    SGD Pharma speeds up time to market with industry first Ready-to-Use Nest & Tub packaging solution for molded glass vials

    Increased demand for parenteral drugs generated by the Covid-19 pandemic has resulted in additional pressures being placed on biopharmaceutical companies to accelerate their time-to-market. This new RTU primary and secondary packaging combination from SGD Pharma offers biopharmaceutical producers the flexibility they need to deliver innovative medicines to patients significantly faster.

    18 Jun 21

    SGD Pharma upgrades its Chinese plant toward an automated and improved production

    SGD Pharma upgrades its Chinese plant toward an automated and improved production

    SGD Pharma's Zhanjiang (China) plant produces 1.2 million Type II & III flint molded glass vials daily for the parenteral market and for health care beauty products. With a surface of ​​85,000m2, the plant included a glass furnace, 6 production lines, an ISO 8 clean room of 2000m2, a resorting room and a customization workshop. In early 2018, SGD Pharma invested 7 million Euros to improve the automation and the production, including the rebuilding of the furnace, to make the plant an exemplary production center.

    01 May 18

    High-precision management for blood derivative products

    High-precision management for blood derivative products

    Drugs made from blood plasma, blood derivative products are used in the treatment of numerous diseases, such as hemophilia or immunodeficiency. Their use is often associated with life threatening situations. Involved in this sector for the past twenty years, SGD Pharma has worked with the main companies and thus developed a high-level expertise to manufacture over 100 million vials specifically dedicated to these derivatives each year.

    12 Aug 16

    • Jo Webb
    • News Folder
    • English
    • Created 15 Jun 2018
    • Modified 15 Jun 2018
    • Hits 1302
    Conzept International
    Quadpack
    Webpackaging